Atopic dermatitis Trials in Doral, United States
Conditions / Atopic dermatitis / Doral, United States
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
24 total trials for this combination
Showing top 10 of 24 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05882877 | A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03796676 | JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT05995964 | A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis | RECRUITING | PHASE2 |
| NCT05651711 | A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) | COMPLETED | PHASE3 |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden | RECRUITING | — |
| NCT03607422 | A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) | COMPLETED | PHASE3 |
| NCT05899816 | A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) | COMPLETED | PHASE3 |
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | COMPLETED | PHASE3 |
| NCT06389136 | A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab | RECRUITING | — |
| NCT05155085 | A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis | TERMINATED | PHASE2 |